Croda International (49GP) AI Stock Analysis

• Market Cap: £4.05B
• Dividend Yield: 754.29%
• Average Volume (3M): 500.00
• Price to Earnings (P/E): ―
• Beta (1Y): >-0.01
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: UK
• Employees: 6,027
• Sector: Basic Materials
• Sector Strength: 72
• Industry: Chemicals - Specialty
• EPS (TTM): N/A
• Shares Outstanding: 499,000
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 500
• PEG Ratio: -9.95
• Price to Book (P/B): 1.79
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 28.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £97.00
• Price Target Upside: 10.86% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 67 Neutral
• Price Target: 97.00p ▲(10.86%Upside)

Croda International's overall stock score is driven by stable financial performance and a positive earnings call outlook, despite technical signals indicating potential overbought conditions. The absence of P/E ratio and dividend yield data complicates valuation assessment, but the company's strategic positioning and operational improvements provide a supportive backdrop for future growth.

Croda International Business Overview & Revenue Model

Company Description

Croda International Plc is a global specialty chemicals company that focuses on developing, manufacturing, and selling high-performance ingredients and technologies. It operates across various sectors including personal care, life sciences, and performance technologies. Croda is renowned for its innovation in sustainable solutions, offering a diverse range of products that improve everyday applications such as cosmetics, healthcare products, and industrial applications.

How the Company Makes Money

Croda International generates revenue primarily through the sale of its specialty chemical products. The company's key revenue streams include its personal care segment, where it supplies ingredients for cosmetics and skincare products; life sciences, which covers pharmaceutical and healthcare applications; and performance technologies, which includes products for industrial applications like lubricants and coatings. Croda's earnings are bolstered by its commitment to sustainability and innovation, which drive customer demand for eco-friendly and efficient solutions. Additionally, strategic partnerships and collaborations with major companies in various industries contribute to its financial performance, as well as its investment in research and development to continually enhance its product offerings.

Croda International Financial Statement Overview

Summary

Croda International demonstrates a stable financial position with strong margins and a conservative balance sheet. The company maintains healthy cash flow generation relative to net income, although declining revenue and net profit margins indicate challenges in sustaining growth. The balance sheet's solid equity ratio and low leverage are positive indicators of financial health.

Income Statement

Croda International has experienced declining revenue over the past two years, with a 3.92% decrease from 2022 to 2023 and a further 3.92% decrease into 2024. The gross profit margin for 2024 stands at 45.08%, indicating strong control over cost of goods sold. However, the net profit margin has declined to 9.73% from 10.09% in 2023, reflecting challenges in maintaining profitability. The EBIT margin for 2024 is 13.97%, a decrease from 14.60% in 2023, while the EBITDA margin is 22.99%, down from 22.93% in 2023. The company shows resilience in maintaining decent margins despite revenue pressures.

Balance Sheet

The company's balance sheet reflects stability with a debt-to-equity ratio of 0.31 in 2024, showing a conservative leverage position. The return on equity (ROE) is 6.94%, down from 7.27% in 2023, suggesting a slight decline in efficiency at generating profits from equity. Croda's equity ratio stands at 65.03%, indicating a robust equity position relative to total assets, which is a positive indicator of financial health.

Cash Flow

Free cash flow decreased by 12.23% from 2023 to 2024, reflecting challenges in cash generation. The operating cash flow to net income ratio is 2.01, showing strong cash flow generation relative to net income. The free cash flow to net income ratio is 0.87, indicating a healthy conversion of net income into free cash flow. While cash flow metrics show strength in terms of cash generation, the decline in free cash flow growth highlights potential pressure on liquidity.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.63B	1.69B	2.09B	1.89B	1.39B
Gross Profit	733.90M	730.00M	864.90M	825.60M	550.30M
EBITDA	374.50M	388.50M	924.80M	549.40M	369.60M
Net Income	158.50M	171.00M	649.30M	320.80M	201.60M
Balance Sheet
Total Assets	3.51B	3.58B	3.61B	3.29B	3.03B
Cash, Cash Equivalents and Short-Term Investments	166.80M	172.50M	320.60M	112.80M	106.50M
Total Debt	699.10M	710.10M	615.80M	936.00M	907.00M
Total Liabilities	1.21B	1.21B	1.18B	1.53B	1.43B
Stockholders Equity	2.28B	2.35B	2.42B	1.75B	1.59B
Cash Flow
Free Cash Flow	137.60M	156.80M	160.90M	190.50M	166.30M
Operating Cash Flow	319.40M	337.50M	313.30M	349.20M	287.50M
Investing Cash Flow	-139.10M	-409.80M	418.10M	-218.40M	-992.40M
Financing Cash Flow	-182.60M	-52.40M	-550.90M	-111.90M	722.40M

Croda International Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 87.50
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:49GP, the sentiment is Positive. The current price of 87.5 is above the 20-day moving average (MA) of 87.50, below the 50-day MA of 87.52, and above the 200-day MA of 85.92, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 42.49 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:49GP.

Croda International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JMAT	72 Outperform	£3.04B	8.57	15.96%	4.24%	-9.10%	239.75%
49GP	67 Neutral	£4.05B	―		754.29%	―	―
VCT	66 Neutral	£608.83M	20.50	6.65%	8.51%	4.75%	-3.29%
TET	64 Neutral	£121.45M	11.17	8.02%	408.25%	1.12%	-0.70%
ELM	62 Neutral	£965.25M	―	-5.93%	1.05%	0.71%	-274.39%
Sector *	57 Neutral	£2.63B	4.92	-9.48%	141.26%	5.31%	-6.23%
SYNT	52 Neutral	£150.47M	―	-6.25%	―	0.81%	15.63%